Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,070 | 18,208 | 21,957 | 21,390 | 25,451 |
| Depreciation Amortization | 845 | 488 | 243 | 760 | 494 |
| Accounts receivable | 173 | 380 | -13,284 | N/A | -1,712 |
| Accounts payable and accrued liabilities | -620 | -469 | 442 | N/A | -65 |
| Other Working Capital | -1,072 | 62 | -13,416 | 90 | -1,749 |
| Other Operating Activity | -240 | 409 | 13,103 | 380 | 1,906 |
| Operating Cash Flow | $13,156 | $19,078 | $9,045 | $22,620 | $24,325 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -404 | -352 | -11 | -180 | -75 |
| Purchase Of Investment | -100,253 | -45,706 | -13,141 | N/A | -46,248 |
| Sale Of Investment | 39,079 | 32,699 | 15,651 | N/A | 17,900 |
| Other Investing Activity | 0 | 0 | 0 | -17,860 | 1,140 |
| Investing Cash Flow | $-61,578 | $-13,359 | $2,499 | $-18,040 | $-27,283 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 60,329 | 60,307 | -1,320 | N/A | 126 |
| Common Stock Repurchased | -3,540 | -2,073 | N/A | N/A | -44 |
| Other Financing Activity | 0 | 0 | 0 | -900 | 0 |
| Financing Cash Flow | $56,789 | $58,234 | $-1,320 | $-900 | $82 |
| Beginning Cash Position | 10,511 | 10,511 | 10,511 | 6,830 | 6,837 |
| End Cash Position | 18,878 | 74,464 | 20,735 | 10,510 | 3,961 |
| Net Cash Flow | $8,367 | $63,953 | $10,224 | $3,670 | $-2,876 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,156 | 19,078 | 9,045 | 22,620 | 24,325 |
| Capital Expenditure | -404 | -352 | -11 | N/A | -141 |
| Free Cash Flow | 12,752 | 18,726 | 9,034 | 22,620 | 24,184 |